From Crohn disease to uncomplicated urinary tract infections and beyond, the FDA issued several high-impact drug approvals last month.

Popular Western medicines for diseases including cancer and diabetes have been caught in the escalating U.S.-China trade war, ...

The first patient with small cell lung cancer has been dosed in a phase 1/2 trial investigating first-line iadademstat plus ...

We are delighted to welcome Dr. Nicacio to the Protara team,” said Jesse Shefferman, Chief Executive Officer of Protara Therapeutics. “As a proven leader with deep expertise spanning all stages of ...

In the Phase III DeLLphi-304 trial, patients with small cell lung cancer administered Imdelltra achieved a statistically ...

Arcus Biosciences, Inc.’s RCUS share price has dipped by 5.50%, which has investors questioning if this is right time to buy.

In Indiana, AstraZeneca has a production site for its blockbuster cancer drug durvalumab and Eli Lilly also makes its popular diabetes and weight-loss drug tirzepatide there, the data showed.

The European Commission has cleared AZ's PD-L1 inhibitor Imfinzi (durvalumab) alongside PARP inhibitor Lynparza (olaparib) for patients with primary advanced or recurrent endometrial cancer with ...